These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2894374

  • 1. Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells.
    Ewton DZ, Spizz G, Olson EN, Florini JR.
    J Biol Chem; 1988 Mar 15; 263(8):4029-32. PubMed ID: 2894374
    [Abstract] [Full Text] [Related]

  • 2. Type beta transforming growth factor is an inhibitor of myogenic differentiation.
    Massagué J, Cheifetz S, Endo T, Nadal-Ginard B.
    Proc Natl Acad Sci U S A; 1986 Nov 15; 83(21):8206-10. PubMed ID: 3022285
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens.
    Kyprianou N, Isaacs JT.
    Endocrinology; 1988 Oct 15; 123(4):2124-31. PubMed ID: 2901342
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Functional receptors for transforming growth factor-beta are retained by biochemically differentiated C2 myocytes in growth factor-deficient medium containing EGTA but down-regulated during terminal differentiation.
    Hu JS, Olson EN.
    J Biol Chem; 1990 May 15; 265(14):7914-9. PubMed ID: 2159464
    [Abstract] [Full Text] [Related]

  • 7. Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.
    Tucker RF, Branum EL, Shipley GD, Ryan RJ, Moses HL.
    Proc Natl Acad Sci U S A; 1984 Nov 15; 81(21):6757-61. PubMed ID: 6208555
    [Abstract] [Full Text] [Related]

  • 8. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture.
    Olwin BB, Hauschka SD.
    J Cell Biol; 1988 Aug 15; 107(2):761-9. PubMed ID: 2843547
    [Abstract] [Full Text] [Related]

  • 9. Distribution and modulation of the cellular receptor for transforming growth factor-beta.
    Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB.
    J Cell Biol; 1987 Aug 15; 105(2):965-75. PubMed ID: 2887577
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of receptors for type-beta transforming growth factor.
    Massagué J.
    Methods Enzymol; 1987 Aug 15; 146():174-95. PubMed ID: 2891018
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and binding of radioactively labeled porcine transforming growth factor type beta.
    Ruff E, Rizzino A.
    Biochem Biophys Res Commun; 1986 Jul 31; 138(2):714-9. PubMed ID: 2874805
    [Abstract] [Full Text] [Related]

  • 13. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors.
    Like B, Massagué J.
    J Biol Chem; 1986 Oct 15; 261(29):13426-9. PubMed ID: 2875996
    [Abstract] [Full Text] [Related]

  • 14. Structure and properties of the cellular receptor for transforming growth factor type beta.
    Fanger BO, Wakefield LM, Sporn MB.
    Biochemistry; 1986 Jun 03; 25(11):3083-91. PubMed ID: 2873833
    [Abstract] [Full Text] [Related]

  • 15. Decreased transforming growth factor-beta response and binding in insulin-independent teratoma-derived cell lines with increased tumorigenic properties.
    Serrero G, Zhou J, Mills D, LePak N.
    J Cell Physiol; 1991 Dec 03; 149(3):503-11. PubMed ID: 1660484
    [Abstract] [Full Text] [Related]

  • 16. An assay for type-beta transforming growth factor receptor.
    Wakefield LM.
    Methods Enzymol; 1987 Dec 03; 146():167-73. PubMed ID: 2891017
    [No Abstract] [Full Text] [Related]

  • 17. Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.
    Massagué J, Kelly B.
    J Cell Physiol; 1986 Aug 03; 128(2):216-22. PubMed ID: 2874147
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression.
    Spizz G, Hu JS, Olson EN.
    Dev Biol; 1987 Oct 03; 123(2):500-7. PubMed ID: 3477514
    [Abstract] [Full Text] [Related]

  • 19. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD, Birnbaum LS.
    Cancer Res; 1989 Jun 15; 49(12):3196-202. PubMed ID: 2541899
    [Abstract] [Full Text] [Related]

  • 20. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5.
    Morris JC, Ranganathan G, Hay ID, Nelson RE, Jiang NS.
    Endocrinology; 1988 Sep 15; 123(3):1385-94. PubMed ID: 3165340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.